Biota's influenza drug fails in mid-stage study

Fri Aug 1, 2014 7:10am EDT

Aug 1 (Reuters) - Biota Pharmaceuticals Inc said its experimental influenza drug failed to meet the main goal in a mid-stage study.

The drug, Laninamivir octanoate, is undergoing development to treat influenza A and B infections. (Reporting by Natalie Grover in Bangalore; Editing by Savio D'Souza)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

A tourist takes a plunge as she swims at Ngapali Beach, a popular tourist site, in the Thandwe township of the Rakhine state, October 6, 2013. Picture taken October 6, 2013. REUTERS/Soe Zeya Tun (MYANMAR - Tags: SOCIETY) - RTR3FOI0

Where do you want to go?

We look at when to take trips, budget considerations and the popularity of multigenerational family travel.   Video